B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules

Cancer Research

Volumn 57, Issue 21, 1997, Pages 4940-4947

  Trentin, Livio ^a,b   Zambello, Renato ^a,b   Sancetta, Rosaria ^a   Facco, Monica ^a   Cerutti, Andrea ^a,c   Perin, Alessandra ^a   Siviero, Marta ^a   Basso, Umberto ^a   Bortolin, Michela ^a   Adami, Fausto ^a   Agostini, Carlo ^a   Semenzato, Gianpietro ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Vicenza Hospital   (Italy)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD27 ANTIGEN; CD30 ANTIGEN; CD40 ANTIGEN; CD5 ANTIGEN; CD70 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN GP 39; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HAIRY CELL LEUKEMIA; HUMAN; HUMAN CELL; LYMPHOPROLIFERATIVE DISEASE; MALE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANTIGENS, CD; B-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKEMIA, B-CELL, CHRONIC; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; NEOPLASM PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 0030775137     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Harris, N. L., Jaffe, E. S., Stein, H., Banks, P. M., Chan, J. K. C., Cleary, M. L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K. C., Grogan, T. M., Isaacson, P. G., Knowles, D. M., Mason, D. Y., Mueller-Hermeling, H. K., Pileri, S. A., Piris, M. A., Ralfkiaer, E., and Warnke, R. A. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood, 84: 1361-1392, 1994.
2. Foon, K., and Todd, R. F. I. Immunologic classification of leukemia and lymphoma. Blood, 68: 1-31, 1986.
3. De Totero, D., Tazzari, P. L., Lauria, F., Raspadori, D., Francia di Celle, P., Carbone, A., Gobbi, M., and Foà, R. Phenotypic analysis of hairy cell leukemia: "variant" cases express the interleukin-2 receptor β chain, but not the α chain (CD25). Blood, 82: 528-535, 1993.
4. Smith, C. A., Gruss, H. J., Davis, T., Anderson, D., Farrah, T., Baker, E., Sutherland, G. R., Brannan, C. I., Copeland, N. G., Jankins, N. A., Grabstein, K. H., Gliniak, B., McAlister, I. B., Fanslow, W., Anderson, M., Falk, B., Gimpel, S., Gillis, S., Din, W. S., Goodwin, R. G., and Armitage, R. J. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology for TNF. Cell. 73: 1349-1360, 1993.
5. Falini, B., Pileri, S., Pizzolo, G., Durkop, H., Flenghi, L., Stirpe, F., Martelli, M. F., and Stein, H. CD30(Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood, 85: 1-14, 1995.
6. Hollenbaugh, D., Ochs, H. D., Noelle, R. J., Ledbetter, J. A., and Aruffo, A. The role of CD40 and its ligand in the regulation of immune response. Immunol. Rev., 138: 23-37, 1994.
7. Goodwin, R. G., Anderson, M. R., Smith, C. A., Armitage, R. J., Schoenbom, M. A., Davis-Smith, T., Hennen, K., Falk, B., Cosman, D., Baker, E., Sutherland, G. R., Grabstein, K. H., Farrah, T., Giri, J. G., and Beckmann, M. P. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell, 73: 447-456, 1993.
8. Gruss, H. J., and Dower, S. K. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood, 85: 3378-3404, 1995.
9. Bazzoni, F., and Beutler, B. The tumor necrosis factor ligand and receptor families. N. Engl, J. Med., 334: 1717-1725, 1996.
10. Clark, E. A., and Ledbetter, J. A. How B and T cells talk to each other. Nature (Lond.), 367: 425-428, 1994.
11. June, C. H., Bluestone, J. A., Nadler, L. M., and Thompson, C. B. The B7 and CD28 receptor families. Immunol. Today. 15: 321-331, 1994.
12. Schultze, J., Nadler, L. M., and Gribben, J. G. B7-mediated costimulation and the immune response. Blood Rev., 10: 111-127, 1996.
13. Lynch, D. H., Ramsdell, F., and Alderson, M. R. Fas, and FasL in the homeostatic regulation of immune responses. Immunol. Today, 16: 569-574, 1994.
14. Hintzen, R. Q., de Jong, R., Lens, S. M. A., and van Lier, R. A. W. CD27: marker and mediator of T cell activation? Immunol. Today, 15: 307-311, 1994.
15. Durie, F. H., Foy, T. M., Masters, S. R., Laman, J. D., and Noelle, R. J. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today, 15: 406-411, 1994.
16. Cordingley, F. T., Bianchi, A., Hoffbrand, A. V., Reittie, J. E., Heslop, H. E., Vyakarnam, A., Turner, M., Meager, A., and Brenner, M. K. Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet, 1: 969-971, 1988.
17. Digel, W., Stefanic, M., Schoniger, W., Buck, C., Raghavachar, A., Frickhofen, N., Heimpel, H., and Porzsolt, F. Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia. Blood, 73: 1242-1246, 1989.
18. Digel, W., Schoniger, W., Stefanic, M., Janssen, H., Buck, C., Schmid, M., Raghavachar, A., and Porzsolt, F. Receptors for tumor necrosis factor on neoplastic B cells from chronic lymphocytic leukemia are expressed in vitro but not in vivo. Blood, 76: 1607-1613, 1990.
19. Trentin, L., Zambello, R., Agostini, C., Siviero, F., Adami, F., Marcolongo, R., Raimondi, R., Chisesi, T., Pizzolo, G., and Semenzato, G. Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders. Blood. 81: 752-758, 1993.
20. Trentin, L., Zambello, R., Agostini, C., Enthammer, C., Cerutti, A., Adami, F., Zamboni, S., and Semenzato, G. Expression and regulation of tumor necrosis factor, interleukin-2, and hematopoietic growth factor receptors in B-cell chronic lymphocytic leukemia. Blood, 84: 4249-4253, 1994.
21. Foà, R., Massaia, M., Cardona, S., Gillio Tos, A., Bianchi, A., Attisano, C., Guarini, A., Francia di Celle, P., and Fierro, M. Production of tumor necrosis factor α (TNF) by B-cell chronic lymphocytic leukemia cells. A possible regulatory role of TNF in the progression of the disease. Blood, 76: 393-400, 1990.
22. de Bruin, P. C., Gruss, H. J., van der Valk, P., Willemze, R., and Meijer, C. J. L. M. CD30 expression in normal and neoplastic lymphoid tissue: biological aspects and clinical implications. Br. J. Haematol., 9: 1620-1627, 1995.
23. Younes, A., Consoli, U., Zhao, S., Snell, V., Thomas, E., Gruss, H. J., Cabanillas, F., and Andreeff, M. CD30 ligand is expressed on resting normal and malignant B lymphocytes. Br. J. Haematol., 93: 569-571, 1996.
24. Ranheim, E. A., Cantwell, M. J., and Kipps, T. J. Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells. Blood, 85: 3556-3565, 1995.
25. Lederman, S., Yellin, M. J., Cleary, A. M., Pernis, A., Inghirami, G., Cohn, L. E., Covey, L. R., Lee, J. J., Rothman, P., and Chess, L. T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig switch recombination and rescues B cells from programmed cell death. J. Immunol., 152: 2163-2171, 1994.
26. Rai, K. R., Sawitsky, A., Cronkite, E. P., Chanana, A. D., Levy, R. N., and Pasternack, B. S. Clinical staging of chronic lymphocytic leukemia. Blood, 46: 219-225, 1975.
27. Trentin, L., Zambello, R., Agostini, C., Ambrosetti, A., Chisesi, T., Raimondi, R., Bulian, P., Pizzolo, G., and Semenzato, G. Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia. Blood, 75: 1525-1530, 1990.
28. Cerutti, A., Trentin, L., Zambello, R., Sancetta, R., Milani, A., Tassinari, C., Adami, F., Agostini, C. and Semenzato, G. The CD5/CD72 receptor system is coexpressed with several functionally relevant counterstructures on human B cells and delivers a critical signaling activity. J. Immunol., 157: 1854-1862, 1996.
29. Trentin, L., Cerutti, A., Zambello, R., Sancetta, R., Tassinari, C., Facco, M., Adami, F., Rodeghiero, F., Agostini, C., and Semenzato, G. Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders. Blood, 87: 3327-3335, 1996.
30. Grammer, A. C., Bergman, M. C., Miura, Y., Fujita, K., Davis, L. S., and Lipsky, P. E. The CD40 ligand expressed by B cells costimulates B cell responses. J. Immunol., 154: 4996-5010, 1995.
31. Scott, D. W., Grdina, T., and Shi, Y. T cells commit suicide, but B cells are murdered. J. Immunol., 156: 2352-2356, 1996.
32. Nishioka, Y., and Lipsky, P. E. The role of CD40-CD4O ligand interaction in human T cell-B cell collaboration. J. Immunol., 153: 1027-1036, 1994.
33. Schattner, E. J., Elkon, K. B., Yoo, D., Tumang, J., Krammer, P. H., Crow, M. K., and Friedman, S. M. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J. Exp. Med., 182: 1557-1565, 1995.
34. Wang, J., Taniuchi, I., Howard, M., Cooper, M. D., and Watanabe, T. Expression and function of Fas antigen on activated murine B cells. Eur. J. Immunol., 26: 92-96, 1996.
35. Garrone, P., Neidhardt, E-M., Garcia, E., Galibert, L., van Kooten, C., and Bancherau, J. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J. Exp. Med., 182: 1265-1273, 1995.
36. Rathmell, J. C., Townsend, S. E., Xu, J. C., Flavell, R. A., and Goodnow, C. C. Expansion or elimination of B cells in vivo: dual roles for CD40-and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell, 87: 319-429, 1996.
37. Caligaris-Cappio, F. B-chronic lymphocytic leukemia: a malignancy of anti-self B cells. Blood, 87: 2615-1620, 1996.
38. Buhlmann, J. E., and Noelle, R. J. Therapeutic potential for blockade of the CD40 ligand, gp39. J. Clin. Immunol., 16: 83-89, 1996.
39. Durkop, H., Latza, U., Hummel, M., Eitelbach, F., Seed, B., and Stein, H. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell, 68: 421-427, 1992.
40. Grewal, I. S., and Flavell, R. A. A central role of CD40 ligand in the regulation of CD4+ T-cell responses. Immunol. Today, 17: 410-414, 1996.
41. Gray, D., Siepmann, K., van Essen, D., Poudrier, J., Wykes, M., Jainandunsing, S., Bergthorsdottir, S., and Dullforce, P. B-T lymphocyte interactions in the generation and survival of memory cells. Immunol. Rev., 150: 45-61, 1996.
42. Bancherau, J., Briere, F., Liu, Y. J., and Rousset, F. Molecular control of B lymphocyte growth and differentiation. Stem Cells, 12: 278-288, 1994.
43. Klaus, S. J., Berberich, I., Shu, G., and Clark, E. A. CD40 and its ligand in the regulation of humoral immunity. Semin. Immunol., 6: 279-286, 1994.